Related Experiment Video
Updated: May 11, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2
Yosuke Harazono1, Tomoki Muramatsu, Hironori Endo
1Department of Molecular Cytogenetics, Tokyo Medical and Dental University, Tokyo, Japan.
Abstract:
Recently, the epithelial-to-mesenchymal transition (EMT) has been demonstrated to contribute to normal and disease processes including cancer progression. To explore EMT-suppressive microRNAs (miRNAs), we established a cell-based reporter system using a stable clone derived from a pancreatic cancer cell line, Panc1, transfected with a reporter construct containing a promoter sequence of CDH1/E-cadherin in the 5' upstream region of the ZsGreen1 reporter gene. Then, we performed function-based screening with 470 synthetic double-stranded RNAs (dsRNAs) mimicking human mature miRNAs using the system and identified miR-655 as a novel EMT-suppressive miRNA. Overexpression of miR-655 not only induced the upregulation of E-cadherin and downregulation of typical EMT-inducers but also suppressed migration and invasion of mesenchymal-like cancer cells accompanied by a morphological shift toward the epithelial phenotype. In addition, we found a significant correlation between miR-655 expression and a better prognosis in esophageal squamous cell carcinoma (ESCC). Moreover, ZEB1 and TGFBR2, which are essential components of the TGF-b signaling pathway, were identified as direct targets of miR-655, suggesting that the activation of the TGF-b-ZEB1-E-cadherin axis by aberrant downregulation of miR-655 may accelerate cancer progression.
Insights
MicroRNA-655 (miR-655) suppresses cancer progression by inhibiting the epithelial-to-mesenchymal transition (EMT). This novel EMT-suppressive miRNA targets ZEB1 and TGFBR2, offering potential therapeutic strategies for cancers like esophageal squamous cell carcinoma.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- The epithelial-to-mesenchymal transition (EMT) is implicated in normal development and disease, notably cancer progression.
- Identifying microRNAs (miRNAs) that suppress EMT is crucial for understanding and potentially treating cancer.
Purpose of the Study:
- To discover novel microRNAs (miRNAs) that inhibit the epithelial-to-mesenchymal transition (EMT).
- To investigate the role of miR-655 in cancer cell migration, invasion, and prognosis.
Main Methods:
- Established a cell-based reporter system using Panc1 pancreatic cancer cells and a CDH1/E-cadherin promoter-driven reporter construct.
- Conducted a functional screen of 470 synthetic microRNA mimics to identify EMT-suppressive miRNAs.
- Validated targets and assessed the impact of miR-655 overexpression on cancer cell phenotype, migration, invasion, and prognosis.
Main Results:
- Identified miR-655 as a novel EMT-suppressive miRNA.
- Overexpression of miR-655 upregulated E-cadherin, downregulated EMT-inducers, and suppressed cancer cell migration and invasion.
- Found a correlation between higher miR-655 expression and better prognosis in esophageal squamous cell carcinoma (ESCC).
- Identified ZEB1 and TGFBR2 as direct targets of miR-655, implicating the TGF-b signaling pathway.
Conclusions:
- miR-655 acts as a tumor suppressor by inhibiting EMT, targeting key components of the TGF-b signaling pathway (ZEB1, TGFBR2).
- Aberrant downregulation of miR-655 may accelerate cancer progression through activation of the TGF-b-ZEB1-E-cadherin axis.
- miR-655 represents a potential therapeutic target for cancers exhibiting EMT, including esophageal squamous cell carcinoma.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
TGF - β Signaling Pathway
